首页> 美国卫生研究院文献>International Journal of Molecular Sciences >A Novel Preparation Method for Camptothecin (CPT) Loaded Folic Acid Conjugated Dextran Tumor-Targeted Nanoparticles
【2h】

A Novel Preparation Method for Camptothecin (CPT) Loaded Folic Acid Conjugated Dextran Tumor-Targeted Nanoparticles

机译:喜树碱(CPT)负载叶酸共轭葡聚糖肿瘤靶向纳米粒子的新型制备方法。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this study, folic-dextran-camptothecin (Fa-DEX-CPT) tumor-targeted nanoparticles were produced with a supercritical antisolvent (SAS) technique by using dimethyl sulfoxide (DMSO) as a solvent and carbon dioxide as an antisolvent. A factorial design was used to reveal the effect of various process parameters on the mean particle size (MPS) and morphology of the particles formed. Under the optimum operation conditions, Fa-DEX-CPT nanoparticles with a MPS of 182.21 nm were obtained. Drug encapsulation efficiency and loading efficiency were 62.13% and 36.12%, respectively. It was found that the concentrations of the camptothecin (CPT) and dextran solution had a major influence upon morphology and shape of the final product. In addition, the samples were characterized by Scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FT-IR), Differential scanning calorimetry (DSC) and X-ray diffraction (XRD) with the purpose of developing a suitable targeted drug delivery system for cancer chemotherapy.
机译:在这项研究中,叶酸-葡聚糖-喜树碱(Fa-DEX-CPT)靶向肿瘤的纳米颗粒是通过使用超临界抗溶剂(SAS)技术,使用二甲基亚砜(DMSO)作为溶剂和使用二氧化碳作为抗溶剂来生产的。析因设计用于揭示各种工艺参数对形成的颗粒的平均粒径(MPS)和形态的影响。在最佳操作条件下,获得了MPS为182.21 nm的Fa-DEX-CPT纳米粒子。药物包封率和载药率分别为62.13%和36.12%。发现喜树碱(CPT)和葡聚糖溶液的浓度对最终产品的形态和形状有重大影响。此外,样品的特征在于扫描电子显微镜(SEM),傅立叶变换红外光谱(FT-IR),差示扫描量热法(DSC)和X射线衍射(XRD),目的是开发合适的靶向药物递送系统用于癌症化疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号